ISTO Technologies is an orthobiologics firm developing biologic products to regenerate and restore function to damaged cartilage and bone.
ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 29, 2015 | Grant | $1.20M | 1 | — | — | Detail |
Aug 14, 2002 | Grant | $750K | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 25, 2022
Finnt
|
Seed | $3.50M | Cryptocurrency | — |
Mar 2, 2022
Polymer Labs
|
Seed | $3.60M | Blockchain | — |
Jun 9, 2021
Eight Sleep
|
Angel | — | Consumer Electronics | — |
Apr 1, 2021
Goody
|
Series A | $13.10M | Consumer | — |
Mar 10, 2021
Clara
|
Pre-seed | $3.50M | Credit Cards | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | — | Grant |